Related references
Note: Only part of the references are listed.Antimicrobial Resistance in the 21st Century: A Multifaceted Challenge
O. Nolte
PROTEIN AND PEPTIDE LETTERS (2014)
In Vivo Activity of Optimized Apidaecin and Oncocin Peptides Against a Multiresistant, KPC-Producing Klebsiella pneumoniae Strain
Eszter Ostorhazi et al.
PROTEIN AND PEPTIDE LETTERS (2014)
Cellular Uptake of Apidaecin 1b and Related Analogs in Gram-negative Bacteria Reveals Novel Antibacterial Mechanism for Proline-rich Antimicrobial Peptides
Nicole Berthold et al.
PROTEIN AND PEPTIDE LETTERS (2014)
Controlled Systemic Release of Therapeutic Peptides from PEGylated Prodrugs by Serum Proteases
Friederike Inga Nollmann et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Novel Apidaecin 1b Analogs with Superior Serum Stabilities for Treatment of Infections by Gram-Negative Pathogens
Nicole Berthold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
New drugs for methicillin-resistant Staphylococcus aureus: an update
Krishan Kumar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Functional Characterization of SbmA, a Bacterial Inner Membrane Transporter Required for Importing the Antimicrobial Peptide Bac7(1-35)
Giulia Runti et al.
JOURNAL OF BACTERIOLOGY (2013)
Structural Studies on the Forward and Reverse Binding Modes of Peptides to the Chaperone DnaK
Michael Zahn et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
Api88 Is a Novel Antibacterial Designer Peptide To Treat Systemic Infections with Multidrug-Resistant Gram-Negative Pathogens
Patricia Czihal et al.
ACS CHEMICAL BIOLOGY (2012)
Intracellular Toxicity of Proline-Rich Antimicrobial Peptides Shuttled into Mammalian Cells by the Cell-Penetrating Peptide Penetratin
Anne Hansen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Rational Design of Oncocin Derivatives with Superior Protease Stabilities and Antibacterial Activities Based on the High-Resolution Structure of the Oncocin-DnaK Complex
Daniel Knappe et al.
CHEMBIOCHEM (2011)
Broad-spectrum antimicrobial efficacy of peptide A3-APO in mouse models of multidrug-resistant wound and lung infections cannot be explained by in vitro activity against the pathogens involved
Eszter Ostorhazi et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
The proline-rich peptide Bac7(1-35) reduces mortality from Salmonella typhimurium in a mouse model of infection
Monica Benincasa et al.
BMC MICROBIOLOGY (2010)
The designer proline-rich antibacterial peptide A3-APO is effective against systemic Escherichia coli infections in different mouse models
Dora Szabo et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Allosteric Coupling between the Lid and Interdomain Linker in DnaK Revealed by Inhibitor Binding Studies
Markus Liebscher et al.
JOURNAL OF BACTERIOLOGY (2009)
Role of the Escherichia coli SbmA in the antimicrobial activity of proline-rich peptides
Maura Mattiuzzo et al.
MOLECULAR MICROBIOLOGY (2007)
Simple procedures for the construction of a robust and cost-effective cell-free protein synthesis system
Tae-Wan Kim et al.
JOURNAL OF BIOTECHNOLOGY (2006)
Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection
Tomoya Baba et al.
MOLECULAR SYSTEMS BIOLOGY (2006)
The bacterial ribosome as a target for antibiotics
J Poehlsgaard et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin
G Kragol et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Interaction between heat shock proteins and antimicrobial peptides
L Otvos et al.
BIOCHEMISTRY (2000)
Using photolabile ligands in drug discovery and development
G Dormán et al.
TRENDS IN BIOTECHNOLOGY (2000)
Share Paper
